The Money Blog

In my previous piece on Confessions from the Passion Trap, I shared why technical founders: especially those in deeptech and healthtech: often get stuck when their brilliant technology doesn't trans...

Last week, I shared how smart founders use alignment systems to survive (and win) when competitors have more cash. The response was overwhelming: dozens of deeptech and healthtech CEOs asking the sa...

Last week, we talked about how evidence loops turn learning velocity into fundraising momentum. But here's the thing: all those beautiful evidence loops mean nothing if you can't present them clearl...

Here's the thing about being outfunded: it forces you to get really, really good at being right.

While your well-funded competitors are burning through Series A cash building products nobody wants,...

I'll be honest, I used to think strategic detachment was corporate BS. Another buzzword consultants threw around to sound smart while founders did the real work.

Then I watched a brilliant healthte...

Most deeptech and healthtech founders obsess over the wrong metrics when preparing for fundraising rounds. They polish their burn rates, perfect their runway projections, and stress about monthly re...

Most deeptech and healthtech founders walk into investor meetings armed with burn rate projections and runway calculations. Meanwhile, their better-funded peers are talking about something entirely ...

You've spent years perfecting your deeptech/healthtech breakthrough. The science is solid. The potential is massive. But here's the brutal truth: 92% of technical founders who let passion drive stra...

92% of co-founder breakups happen in the first 5 years. And in deeptech/healthtech? The stakes are even higher: your IP, years of R&D, and that breakthrough technology you've been perfecting could ...

Here's the brutal truth: 92% of deeptech and healthtech founders tell investors boring stories that kill deals before they even start.

You've got groundbreaking science, revolutionary technology, a...

Here's the brutal truth that 92% of deeptech and healthtech founders refuse to admit: your relentless pursuit of growth metrics is actually repelling the smartest capital in the market.

While yo...

Here's the brutal truth: 92% of deeptech and healthtech startups miss their optimal exit valuation because they treat exit planning like an afterthought.

But what if I told you that founders who na...